RVNC / Revance Therapeutics, Inc. - Institutionelt ejerskab - Købere

Revance Therapeutics, Inc.
US ˙ NasdaqGM ˙ US7613301099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Revance Therapeutics, Inc., omfatter .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-13 13F Advisor Group Holdings, Inc. 3.705 11
2025-03-26 NP SWSSX - Schwab Small-Cap Index Fund This fund is a listed as child fund of Charles Schwab Investment Management Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 253.599 0,05 921 -38,46
2025-03-31 NP Innovator ETFs Trust - Innovator U.S. Small Cap Managed Floor ETF 508 71,04 2 0,00
2025-05-05 13F IFP Advisors, Inc 0 0
2025-03-28 NP MNA - IQ Merger Arbitrage ETF 282.392 70,03 1.025 4,70
2025-04-01 NP KCXIX - Knights of Columbus U.S. All Cap Index Fund I Shares 376 180,60 1 -75,00
2025-04-01 NP RSSL - Global X Russell 2000 ETF 59.697 5,15 217 -35,33
2025-03-28 NP SLPIX - Small-cap Profund Investor Class 116 18,37 0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista